April 28-30, 2026 | Rome Cavalieri

22 Jan Precigen

Posted at 21:06h in by

Helen Sabzevari, Ph.D., President and CEO

April 29 | 11:45am | Salone dei Cavalieri, Section 1

Germantown, MD

(NASDAQ: PGEN)

Precigen is a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to address difficult-to-treat diseases with high unmet patient need. Precigen is dedicated to advancing scientific breakthroughs from proof-of-concept through commercialization. With a strong commitment to innovation, Precigen is developing a robust pipeline of differentiated therapies across its core therapeutic areas of immuno-oncology, autoimmune disorders, and infectious diseases.

www.Precigen.com



About the Event

The Cell & Gene Meeting on the Mediterranean is the leading conference bringing together the ATMP community from Europe and beyond. Covering a wide range of commercialization topics from market access and regulatory issues to manufacturing and financing the sector, this program features expert-led panels, extensive one-on-one partnering capabilities, exclusive networking opportunities, and 50+ dedicated presentations by leading publicly traded and privately held companies in the space. Join ARM for Europe’s premier conference for advanced therapies.

Dates & Location

April 28-30, 2026
Rome Cavalieri
Via Alberto Cadlolo 101
Rome, Italy

Program Organizer

Linkedin
Facebook
Twitter
Youtube

By using this website you agree to accept our Privacy Policy and Terms & Conditions